Market Analysis — SSH WILLINGBORO
NJ market | 8 hospitals | HHI: nan (Competitive)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
8
Hospitals in Market
844
Total Beds
$0.8B
Market Revenue
Competitive
HHI: nan
None
Moat Rating (2/10)
#6
Market Share Rank
Competitive Moat (Mauboussin Framework)
Based on "Measuring the Moat" adapted for healthcare. Score 0-10: wide (8+), narrow (5-7), none (<5).
Scale Advantageweak
Switching Costslow
Market Share4.0%
Top 3 Concentration84.2%
Network Density0.95
Margin vs Market+6.7%
Bed Util vs Market-8.6%
What This Means
This hospital has a none moat — no moat — commoditized market position, pricing power limited. The NJ market is competitive — many players, value creation must come from operations not market power (HHI: nan).
Implications: Operational improvements are the primary value driver — see the EBITDA bridge. Compare against peers via comparables or see the full NJ market.
Top Competitors
| Hospital | Beds | Revenue | Rev Share | Bed Share |
|---|---|---|---|---|
| VIRTUA MOUNT HOLLY HOSPITAL | 312 | $372M | 44.9% | 37.0% |
| DEBORAH HEART AND LUNG CENTER | 85 | $212M | 25.6% | 10.1% |
| VIRTUA WILLINGBORO HOSPITAL | 149 | $114M | 13.7% | 17.6% |
| MARLTON REHAB HOSPITAL | 61 | $38M | 4.6% | 7.2% |
| WEISMAN CHILDRENS REHAB HOSPITAL | 18 | $nanM | nan% | 2.1% |
| HAMPTON HOSPITAL | 120 | $33M | 4.0% | 14.2% |
| ASPEN HILLS HEALTHCARE CENTER | 30 | $26M | 3.2% | 3.5% |
Regional Payer Mix
■ Medicare 34%■ Medicaid 2%■ Commercial 64%